What Does Ultragenyx Do?

Total employees1528
HeadquartersNovato
Founded2010

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company committed to bringing to patients novel products for the treatment of serious rare and ultra-rare genetic diseases. The company has a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need, where biology is well understood, and for which there are no approved therapies. Ultragenyx focuses on withdrawing from the natural history of these devastating diseases to make a meaningful difference for patients and their families. Their approach involves identifying, acquiring, developing, and commercializing innovative therapies, often leveraging advanced scientific understanding of disease pathways.

Where Is Ultragenyx's Headquarters?

Ultragenyx officeUltragenyx officeUltragenyx officeUltragenyx office
*Images sourced via web search. Rights belong to original owners

HQ Function

The Novato headquarters serves as the central hub for Ultragenyx's global operations, including executive leadership, research and development strategy, corporate administration, and coordination of global commercial and clinical activities.

Notable Features:

The headquarters likely features modern laboratory spaces for research, collaborative office environments designed to foster innovation, and facilities to support its growing global team. Specific architectural details are not widely publicized, but biotech HQs in this region are typically state-of-the-art.

Work Culture:

Ultragenyx fosters a science-driven, patient-focused work culture. Employees are often motivated by the direct impact their work has on individuals with rare diseases. The culture emphasizes collaboration, urgency, integrity, and innovation.

HQ Significance:

The Novato headquarters is strategically important for Ultragenyx's mission, providing a base for its pioneering research into rare diseases and a central point for managing its expanding pipeline and commercial products worldwide.

Values Reflected in HQ: The headquarters likely reflects Ultragenyx's core values: commitment to patients, scientific excellence, innovation, and a collaborative spirit. The design would prioritize functionality for research and development, as well as creating an environment conducive to teamwork.

Location:

Ultragenyx Pharmaceutical Inc. has a growing global presence, with key operations focused in North America (USA and Canada), Europe (centered in Switzerland), and Latin America (with a hub in Brazil). Their functions supported globally include clinical trial management across numerous countries, regulatory submissions to health authorities worldwide, manufacturing and supply chain logistics for their therapies, and commercialization efforts to ensure patient access to their medicines in approved markets.

Street Address:

60 Leveroni Court

City:

Novato

State/Province:

California

Country:

USA

Where Else Does Ultragenyx Operate Around the World?

Brisbane, California, USA

Address: Address not publicly specified for all operational sites, generally in biotech park areas.

Serves as a key R&D and operational site in the San Francisco Bay Area, leveraging the local biotech talent pool and infrastructure.

Basel, Switzerland

Address: Viertelkreis 3, 4104 Oberwil (Basel-Landschaft)

To manage and expand Ultragenyx's presence in Europe, ensuring patient access to its therapies and navigating the European regulatory landscape.

Cambridge, Massachusetts, USA

Address: Gene Therapy Development and Manufacturing Facility (specific address not widely publicized for operational security)

Leverages the strong biotech ecosystem in the Cambridge/Boston area, particularly for specialized areas like gene therapy manufacturing and research.

Sao Paulo, Brazil

Address: Specific office address within Sao Paulo.

To establish and grow Ultragenyx's footprint in Latin America, bringing therapies for rare diseases to patients in these countries.

Buying Intent Signals for Ultragenyx

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Ultragenyx? Meet the Executive Team

As of April 2025, Ultragenyx' leadership includes:

Emil D. Kakkis, M.D., Ph.D. - Chief Executive Officer and President
Clay Hiles - Executive Vice President, Chief Financial Officer
Erik Harris - Executive Vice President, Chief Commercial Officer
Karina O. Daves - Executive Vice President, Chief People Officer
Camille L. Bedrosian, M.D. - Executive Vice President, Chief Medical Officer
Daniel G. O'Connell - Executive Vice President, Chief Legal and Compliance Officer
Dennis Huang - Executive Vice President, Chief Technical Operations and Quality Officer

Who's Investing in Ultragenyx?

Ultragenyx has been backed by several prominent investors over the years, including:

The Vanguard Group, Inc.
BlackRock, Inc.
Capital Research Global Investors
Fidelity Management & Research Company (FMR Co.)
Price (T.Rowe) Associates Inc
State Street Global Advisors (SSgA)

What Leadership Changes Has Ultragenyx Seen Recently?

Hire1
Exits1

In the past 12 months, Ultragenyx saw a key transition in its finance leadership with the retirement of its long-standing CFO and the appointment of a new Chief Financial Officer.

Departures

Mardi C. Dier, Mardi C. Dier retired after a distinguished tenure as CFO, contributing significantly to Ultragenyx's growth.

New Appointments:

Clay Hiles, Clay Hiles joined Ultragenyx as EVP and CFO, bringing extensive experience in biotech finance to the role.

What Technology (Tech Stack) Is Used byUltragenyx?

Discover the tools Ultragenyx uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Ultragenyx Email Formats and Examples

Ultragenyx Pharmaceutical Inc. commonly uses the first initial followed by the last name for its employee email addresses. This is a standard format for many corporations.

[first_initial][last]@ultragenyx.com

Format

ekakkis@ultragenyx.com

Example

85%

Success rate

What's the Latest News About Ultragenyx?

GlobeNewswire • May 7, 2024

Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update

Ultragenyx announced its first-quarter 2024 financial results, highlighting revenue growth from its commercial products Crysvita®, Dojolvi®, and Evkeeza®. The company also provided updates on its clinical pipeline, including progress in gene therapy programs for Osteogenesis Imperfecta and Wilson Disease....more

GlobeNewswire • April 2, 2024

Ultragenyx Announces UX143 (Setrusumab) Phase 3 Interim Data in Pediatric and Adolescent Patients with Osteogenesis Imperfecta (OI) Selected for Late-Breaking Oral Presentation at ECE 2024

Ultragenyx announced that interim data from the Phase 3 Orbit study of setrusumab in pediatric and adolescent patients with OI showed a statistically significant reduction in fracture rate. The data will be presented at the European Congress of Endocrinology (ECE) 2024....more

GlobeNewswire • February 21, 2024

Ultragenyx Reports Fourth Quarter and Full-Year 2023 Financial Results and Corporate Update

Ultragenyx reported its financial results for the fourth quarter and full year 2023, detailing strong revenue performance and advancements across its clinical development programs. The company emphasized its transition towards becoming a profitable rare disease leader....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Ultragenyx, are just a search away.